Example: quiz answers
Search results with tag "Reblozyl"
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
packageinserts.bms.comeach REBLOZYL dose, review the patient’s hemoglobin and transfusion record. Titrate the dose based on responses according to Table 3. Interrupt treatment for adverse reactions as described in Table 4. Discontinue REBLOZYL if a patient does not experience a decrease in transfusion burden after 9 weeks of treatment (administration of 3 doses) at